Keyphrases
COVID-19
100%
Hospitalized Patients
49%
Randomized Controlled Trial
46%
Microbiome
46%
Airway
46%
Bacterial Load
46%
Inhaled Corticosteroids
46%
Scottish
46%
Dipeptidyl Peptidase 1
46%
Brensocatib
46%
Healthcare Workers
46%
Randomized Placebo-controlled Trial
46%
Fluticasone Propionate
31%
Salmeterol
31%
Budesonide
31%
Seroprevalence
25%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
25%
SARS-CoV-2 Antibodies
23%
SFX-01
23%
Neutrophils
23%
Placebo-controlled Trial
23%
Bronchiectasis
23%
Neutrophilic Inflammation
23%
Precision Medicine
23%
Patients with COVID-19
23%
COVID-19 Pandemic
23%
Proteome
23%
Protective Effect
23%
Acute Changes
23%
Sustained Change
23%
Community-acquired Pneumonia
23%
SARS-CoV-2 Infection
20%
Sputum
20%
Severe Disease
20%
Clinical Status
18%
Placebo
16%
Neutrophil Elastase
16%
Nasopharyngeal Swab
15%
Placebo Groups
13%
Risk Factors
13%
Reinfection
12%
Oral Inhibitors
11%
Pulmonary Involvement
11%
25Mg
11%
UK Hospitals
11%
Supplemental Oxygen
11%
Oxygen Saturation
11%
Fatal COVID-19
11%
COVID-19 Infection
11%
Inclusion Criteria
11%
Medicine and Dentistry
COVID-19
69%
Placebo
69%
Dipeptidyl Peptidase
46%
Budesonide/Formoterol
46%
Microbiome
46%
Randomized Controlled Trial
46%
Fluticasone
46%
Salmeterol
46%
Chronic Obstructive Pulmonary Disease
46%
Severe Acute Respiratory Syndrome Coronavirus 2
36%
Sputum
31%
Infection
30%
Community-Acquired Pneumonia
23%
Personalized Medicine
23%
Bronchiectasis
23%
Formoterol
15%
Serine Proteinase
14%
Adverse Event
12%
Neutrophil
12%
Transcription Factor Nrf2
11%
Sulforaphane
11%
Reinfection
11%
Disease
10%
Nasopharyngeal Swab
7%
Induced Sputum
7%
Biological Marker
7%
Physical Examination
7%
Oxygen Saturation
7%
Lymphocyte
7%
Serositis
5%
Antioxidant
5%
Blood Pressure
5%
Anti-Inflammatory Drug
5%